ACTR-02. NRG ONCOLOGY/RTOG 0424: LONG-TERM RESULTS OF A PHASE II STUDY OF TEMOZOLOMIDE-BASED CHEMORADIOTHERAPY REGIMEN FOR HIGH-RISK LOW-GRADE GLIOMAS
Neuro-Oncology | November 5, 2018 | Volume: 20 | Issue: suppl_6 | Pages: vi11-vi11
10.1093/neuonc/noy148.039